−1 120KRW
−57.33 BKRW
200.23 BKRW
33.79 M
About SHINPOONG PHARM
Sector
CEO
Je-Man Yoo
Headquarters
Ansan-si
Website
Employees (FY)
830
Founded
1962
ISIN
KR7019170000
FIGI
BBG000BG6399
Shinpoong Pharmaceutical Co. Ltd. engages in the manufacture and sales of pharmaceutical products. Its products include joint function enhancers, anti inflammatory analgesic drugs, antibiotics, medicine for high blood pressure, and others. The company was founded on June 5, 1962 and is headquartered in Ansan-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 019170 is 13 090 KRW — it has decreased by 1.73% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SHINPOONG PHARM stocks are traded under the ticker 019170.
SHINPOONG PHARM is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track SHINPOONG PHARM financials in yearly and quarterly reports right on TradingView.
Like other stocks, 019170 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHINPOONG PHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 830.00 employees. See our rating of the largest employees — is SHINPOONG PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHINPOONG PHARM EBITDA is −37.07 B KRW, and current EBITDA margin is −18.51%. See more stats in SHINPOONG PHARM financial statements.